Compare Altria Group Inc (MO) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Altria Group Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Altria Group Inc trades at $74.16 (market cap $122.11B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Altria Group Inc is far larger — about 24× Oruka Therapeutics Inc. Common Stock's market cap, and Altria Group Inc pays a 6.07% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Altria Group Inc for 155 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MO | ORKA | |
|---|---|---|
Market Cap | $122.11B | $5.08B |
Volume | 5,621,141 | 685,276 |
Sector | Consumer Staples | Health |
52-Week High | $74.92 | $113.08 |
52-Week Low | $54.72 | $26.19 |
Typical Hold Time | 155 Days | 0 Days |
Enterprise Value | $144.32B | $4.21B |
Dividend Yield | 6.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Altria Group (MO) trades at $71.56, down 0.15% on the day, with a P/E of 15.07 and a net income margin of 39%. Recent earnings show mixed results, with a beat in Q1 2026 but a miss in Q4 2025 and Q2 2026. The technical outlook is bullish based on moving averages, but oscillators suggest caution. Strong cash flow supports a high dividend yield, though negative equity and regulatory risks persist.
The stock presents a high-yield opportunity with a solid dividend history, but faces headwinds from declining margins and a challenging regulatory environment. Analyst consensus is bullish with a $69.71 price target, yet investors must weigh the sustainability of dividends against underlying financial pressures and market volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
